Clinical Trials at University of Hawaii Cancer Center
As of August 2026, 26 paid clinical trials are recruiting at University of Hawaii Cancer Center, located at 2226 LILIHA ST, LEVEL B-2, HONOLULU, HI 96817-1600, phone (808) 547-6881 in Honolulu, Hawaii. Active studies at this site cover conditions such as Malignant Solid Neoplasm, Obesity and Acute Myeloid Leukemia. Compensation typically covers time, travel, and study visits — most studies also offer study-related medical care at no cost to participants.
Recruiting trial data synced daily from ClinicalTrials.gov. Last sync: .
Filter results
26 clinical trials at University of Hawaii Cancer Center
·Clear filters·A Study to Learn About the Medicine Ponsegromab in Adults With Cancer of the Pancreas Which Has Spread and Caused Significant Body Weight Loss and Fatigue
EXoPERT EMERALD Clinical Study
Testing the Addition of a Type of Drug Called Immunotherapy to the Usual Chemotherapy Treatment for Non-small Cell Lung Cancer, an ALCHEMIST Treatment Trial (Chemo-IO [ACCIO])
Evaluating the Addition of Adjuvant Chemotherapy to Ovarian Function Suppression Plus Endocrine Therapy in Premenopausal Patients With pN0-1, ER-Positive/HER2-Negative Breast Cancer and an Oncotype Recurrence Score Less Than or Equal to 25
Colon Adjuvant Chemotherapy Based on Evaluation of Residual Disease
mFOLFIRINOX Versus mFOLFOX With or Without Nivolumab for the Treatment of Advanced, Unresectable, or Metastatic HER2 Negative Esophageal, Gastroesophageal Junction, and Gastric Adenocarcinoma
Osimertinib With or Without Bevacizumab as Initial Treatment for Patients With EGFR-Mutant Lung Cancer
Testing Olaparib for One or Two Years, With or Without Bevacizumab, to Treat Ovarian Cancer
Cost Communication and Financial Navigation in Cancer Patients (COSTCOM)
Inotuzumab Ozogamicin and Frontline Chemotherapy in Treating Young Adults With Newly Diagnosed B Acute Lymphoblastic Leukemia
Testing Higher Dose Radiation Therapy for Locally Advanced Pancreatic Cancer
A Study to Compare Two Surgical Procedures in Individuals With BRCA1 Mutations to Assess Reduced Risk of Ovarian Cancer
Targeted Therapy Directed by Genetic Testing in Treating Patients With Locally Advanced or Advanced Solid Tumors, The ComboMATCH Screening Trial
Docetaxel to Androgen Receptor Pathway Inhibitors in Patients With Metastatic Castration Sensitive Prostate Cancer and Suboptimal PSA Response
Testing Longer Duration Radiation Therapy Versus the Usual Radiation Therapy in Patients With Cancer That Has Spread to the Brain
Lung-MAP: A Master Screening Protocol for Previously-Treated Non-Small Cell Lung Cancer
Testing Shorter Duration Radiation Therapy Versus the Usual Radiation Therapy in Patients With High Risk Prostate Cancer
Immune Checkpoint Inhibitor Toxicity Risk Prediction in Solid Tumors
De-Escalation of Breast Radiation Trial for Hormone Sensitive, HER-2 Negative, Oncotype Recurrence Score Less Than or Equal to 18 Breast Cancer (DEBRA)
S1703 Serum Tumor Marker Directed Disease Monitoring in Patients With Hormone Receptor Positive Her2 Negative Metastatic Breast Cancer
Evaluating Whether an Educational Website Called Current Together After Cancer (CTAC) Improves Follow-up Care for Colorectal Cancer Survivors
Education & Mentorship of Advanced Practice Providers to Increase Community-based Research Within the NCORP Network, COACH-APP Trial
Shorter Chemo-Immunotherapy Without Anthracycline Drugs for Early-Stage Triple Negative Breast Cancer
Mobile Health Dietary Intervention for Stroke Survivors With Prediabetes or Type 2 Diabetes
Effects of Dexrazoxane Hydrochloride on Biomarkers Associated With Cardiomyopathy and Heart Failure After Cancer Treatment
Common conditions studied in Honolulu
- Malignant Solid Neoplasm (9 active studies)
- Obesity (7 active studies)
- Acute Myeloid Leukemia (6 active studies)
- Neuroblastoma (6 active studies)
- Overweight (6 active studies)
- Breast Cancer (5 active studies)
Leading research sponsors in Honolulu
- National Cancer Institute (NCI)
- Children's Oncology Group
- University of Hawaii
- NRG Oncology
- SWOG Cancer Research Network
Frequently asked questions
How many paid clinical trials are currently recruiting in Honolulu?
There are approximately 182 recruiting clinical trials in Honolulu, Hawaii listed on ClinicalTrials.gov. The number changes weekly as new studies open and others close enrollment.
Do clinical trials in Honolulu pay participants?
Most recruiting trials in Honolulu compensate participants for their time, travel, and study visits. Compensation varies by sponsor, study phase, and visit requirements — the exact amount is disclosed by the study team during the informed consent process.
Who can participate in a clinical trial in Honolulu?
Eligibility depends on the specific study. Each trial defines its own inclusion criteria (age, diagnosis, medical history, prior treatments) and exclusion criteria. Both patients with specific conditions and healthy volunteers can qualify, depending on the study design.
What conditions are most commonly studied in Honolulu?
The most common conditions under active study in Honolulu include Malignant Solid Neoplasm (9), Obesity (7), Acute Myeloid Leukemia (6), Neuroblastoma (6), among many others. Browse the list above to explore every recruiting trial.
Are there clinical trials for healthy volunteers in Honolulu?
Yes. Healthy-volunteer studies — often early-phase pharmacology or vaccine trials — recruit in Honolulu on an ongoing basis. Use the "Healthy volunteers only" filter above to view trials that accept participants without the study's target condition.
How do I enroll in a clinical trial in Honolulu?
Click any study title above to see the full study record, including eligibility criteria, visit schedule, and the study team's contact information. Reach out to the central contact or recruiting site directly — they will guide you through screening and informed consent.
Where can I take part in paid clinical trials in Honolulu?
Recruiting research sites in Honolulu include Kapiolani Medical Center for Women and Children, Hawaii Cancer Care Inc - Waterfront Plaza, Queen's Medical Center, among others. Each site lists its open studies and contact information on the study record above — call or email the site coordinator to ask about screening for a specific protocol.
What kinds of studies are recruiting in Honolulu right now?
The largest active categories in Honolulu are Cancer & tumors (78), Diabetes & metabolic (19), Neurology & pain (13). Use the filters above to narrow by therapeutic area, phase, age, or healthy-volunteer eligibility.
What is the address of University of Hawaii Cancer Center?
University of Hawaii Cancer Center is located at 2226 LILIHA ST, LEVEL B-2, HONOLULU, HI 96817-1600. Use the Google Maps link in the intro above to get directions.
How do I contact University of Hawaii Cancer Center?
You can reach University of Hawaii Cancer Center by phone at (808) 547-6881. For questions about a specific trial, use the study coordinator contact listed on the individual study record — click any trial title above to open it.